| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I/II Study of Exisulind in Combination with Docetaxel/Carboplatin in Patients with Metastatic Non–Small-Cell Lung Cancer
|
Jones, Suzanne F.
|
|
2005
|
6 |
Supplement 1 |
p. 361-366
6 p.
|
artikel
|
| 2 |
A Phase II Trial of Preoperative Concurrent Radiation Therapy and Weekly Paclitaxel/Carboplatin for Patients with Locally Advanced Non–Small-Cell Lung Cancer
|
Hainsworth, John D.
|
|
2004
|
6 |
Supplement 1 |
p. 33-42
10 p.
|
artikel
|
| 3 |
A Pilot Trial of Gefitinib in Combination with Docetaxel in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
|
Manegold, Christian
|
|
2005
|
6 |
Supplement 1 |
p. 343-349
7 p.
|
artikel
|
| 4 |
Clinical Benefit of Zoledronic Acid in Patients with Lung Cancer and OtherSolid Tumors: Analysis Based on History of Skeletal Complications
|
Hirsh, Vera
|
|
2004
|
6 |
Supplement 1 |
p. 170-174
5 p.
|
artikel
|
| 5 |
Clinical Significance of Hypoxia-Inducible Factor–1α Messenger RNA Expression in Locally Advanced Non–Small-Cell Lung Cancer After Platinum Agent and Gemcitabine Chemotherapy Followed by Surgery
|
Felip, Enriqueta
|
|
2005
|
6 |
Supplement 1 |
p. 299-303
5 p.
|
artikel
|
| 6 |
Computer-Assisted Image Analysis of Bronchioloalveolar Carcinoma
|
Lau, Derick
|
|
2005
|
6 |
Supplement 1 |
p. 281-286
6 p.
|
artikel
|
| 7 |
Docetaxel for Malignant Mesothelioma: Phase II Study of the Eastern Cooperative Oncology Group
|
Belani, Chandra P.
|
|
2004
|
6 |
Supplement 1 |
p. 43-47
5 p.
|
artikel
|
| 8 |
Dose-Intensive Thoracic Radiation Therapy for Patients at High Risk with Early-Stage Non–Small-Cell Lung Cancer
|
Bogart, Jeffrey A.
|
|
2005
|
6 |
Supplement 1 |
p. 350-354
5 p.
|
artikel
|
| 9 |
Emerging Molecular Biomarkers for Early Detection of Lung Cancer in Patients at High Risk
|
Price, Nancy
|
|
2004
|
6 |
Supplement 1 |
p. 145-148
4 p.
|
artikel
|
| 10 |
Gefitinib in Patients with Brain Metastases from Non–Small-Cell Lung Cancer: Review of 15 Clinical Cases
|
Namba, Yoshinobu
|
|
2004
|
6 |
Supplement 1 |
p. 123-128
6 p.
|
artikel
|
| 11 |
Gemcitabine in Patients with Non–Small-Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Phase II California Cancer Consortium Trial
|
Lara Jr, Primo N.
|
|
2004
|
6 |
Supplement 1 |
p. 102-107
6 p.
|
artikel
|
| 12 |
Neoadjuvant Chemotherapy Followed by Late-Course Accelerated Hyperfractionated Radiation Therapy for Locally Advanced Non–Small-Cell Lung Cancer: Long-Term Results of a Phase I/II Clinical Trial
|
Chen, Ming
|
|
2005
|
6 |
Supplement 1 |
p. 304-309
6 p.
|
artikel
|
| 13 |
Phase II Clinical Trial Data with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer
|
Pérez-Soler, Romàn
|
|
2004
|
6 |
Supplement 1 |
p. S20-S23
4 p.
|
artikel
|
| 14 |
Predictors of Sensitivity and Resistance to Epidermal Growth Factor Receptor Inhibitors
|
Perea, Sofia
|
|
2004
|
6 |
Supplement 1 |
p. S30-S34
5 p.
|
artikel
|
| 15 |
Prospective Randomized Phase III Trial of Etoposide/Cisplatin Versus High-Dose Epirubicin/Cisplatin in Small-Cell Lung Cancer
|
Artal-Cortés, Angel
|
|
2004
|
6 |
Supplement 1 |
p. 175-183
9 p.
|
artikel
|
| 16 |
Results of a Phase II Trial of Gemcitabine in Patients with Non–Small-Cell Lung Cancer and a Performance Status of 2
|
Neubauer, Marcus A.
|
|
2005
|
6 |
Supplement 1 |
p. 245-249
5 p.
|
artikel
|
| 17 |
Role of Epidermal Growth Factor Receptor Mutations in Predicting Sensitivity or Resistance to Targeted Agents in Non–Small-Cell Lung Cancer
|
Reddy, G. Kesava
|
|
2005
|
6 |
Supplement 1 |
p. 338-339
2 p.
|
artikel
|
| 18 |
Split-Course Versus Continuous Thoracic Radiation Therapy for Limited-Stage Small-Cell Lung Cancer: Final Report of a Randomized Phase III Trial
|
Blackstock, A. William
|
|
2005
|
6 |
Supplement 1 |
p. 287-292
6 p.
|
artikel
|
| 19 |
Tirapazamine with Cisplatin and Vinorelbine in Patients with Advanced Non–Small-Cell Lung Cancer: A Phase I/II Study
|
Gatineau, Michel
|
|
2005
|
6 |
Supplement 1 |
p. 293-298
6 p.
|
artikel
|
Tijdschrift beschrijving